# Bounded verification receipt

Date: 2026-10-21. Implementation baseline: `4155b8bd2367e3ef468279f68aad9b7a2d3dfe01`.
This is author verification, not independent acceptance or publication approval.

## Checks executed

Ten Node assertion groups passed at 18:11:47 UTC:

1. Exactly three distinct provisional identities; all live product/variant IDs null.
2. Each legacy decision, exact name, slug and supplier SKU matches its repository seed block.
3. All three referenced local source files matched the initial raw-byte hashes. The final evidence uses Git-blob hashes at the pinned base instead, to avoid platform newline ambiguity; these were separately recalculated and checked.
4. Three card-summary and three detail-copy sections exist; each links its exact primary page and technical sheet and preserves explicit unknowns.
5. No asset rights, photo qualification, packaging verification, image hashes or publication authority are inferred.
6. Overall live counts remain null; local downloaded/generated/published and cleared-photo counts remain zero; no price, inventory, pathway or commerce state is introduced.
7. The R817E liquid/OP720 softgel distinction and broader PDF caution remain recorded.
8. Copy contains no take/daily/timing instructions or screened medical guarantees; no em dash was introduced.
9. Every unrelated task, session and ownership entry remains structurally equal to the baseline; the existing session owns only the new exact lease.
10. All changes are confined to the approved docs subtree and this session's continuity records; no binary media was added.

Additional checks: `node scripts/agentic/xenios-os.mjs validate` PASS; `git diff --check` PASS. Three manufacturer product pages returned HTTP 200. Main-gallery URLs were extracted from actual page records; no URL was synthesized. Technical-sheet extracted text was compared for identity, panel facts and cautions. R817E's broader PDF caution was retained.

## Not proved

- Image pixels were not inspectable through the image-view tool. No actual-photograph status, asset-byte identity, current supplied packaging, readable label, crop or optimized derivative is qualified.
- PDF screenshots exposed no inspectable pixels. Technical-sheet checks are text-only, not layout QA or independent clinical/marketing-claim validation.
- Written Xenios image rights and current live Product Control identity mapping remain missing. No complete authorized current catalog export was available.
- Mito Recharge's full chemical-form/amount panel and all products' storage, current complete warnings, supplied label revision and lot evidence remain unresolved for final content completeness.
- No application, browser journey, database, production, deployment, email or commerce verification was run or implied. No build or heavy test suite was needed for this documentation-only slice.

## Handoff rule

Use only the new documentation subtree for review. Do not merge this historically divergent imagery branch wholesale, copy its stale shared continuity files over current Root state, or treat its old generated media as actual product photographs. Integrate approved content through the existing content table after exact mapping and qualification; photo rights are a separate gate.
